Molecular cloning of a novel isoform of diphosphoinositol polyphosphate phosphohydrolase: A potential target of lithium therapy

Neuropsychopharmacology

Volumn 24, Issue 6, 2001, Pages 640-651

  Hua, Len V ^a,b   Green, Marty ^a   Warsh, Jerry J ^a,b,c   Li, Peter P ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b Department of Pharmacology ^*  (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Diphosphoinositol polyphosphates; Gene expression; Lithium; mRNA differential display; Nudix hydrolase

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; COMPLEMENTARY DNA; DIPHOSPHOINOSITOL POLYPHOSPHATE PHOSPHOHYDROLASE; HALOPERIDOL; IMIPRAMINE; INOSITOL PHOSPHATE; LITHIUM CARBONATE; MESSENGER RNA; PHOSPHATASE; TRANQUILIZER; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CEREBELLUM; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG TARGETING; FRONTAL CORTEX; GENE EXPRESSION; GENE ISOLATION; GENE SEQUENCE; GENETIC CODE; HIPPOCAMPUS; LONG TERM EXPOSURE; MALE; MANIC DEPRESSIVE PSYCHOSIS; MESENCEPHALON; MOLECULAR CLONING; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN FAMILY; RAT; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY;

ACID ANHYDRIDE HYDROLASES; AMINO ACID SEQUENCE; ANIMALS; ANTICONVULSANTS; BASE SEQUENCE; BRAIN; CARBAMAZEPINE; CLONING, MOLECULAR; DNA, COMPLEMENTARY; INOSITOL PHOSPHATES; LITHIUM; MALE; MOLECULAR SEQUENCE DATA; NEURONS; PROTEIN ISOFORMS; PSYCHOTROPIC DRUGS; RATS; RATS, WISTAR; RNA, MESSENGER; SIGNAL TRANSDUCTION; VALPROIC ACID;

EID: 0035023431     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(00)00233-5     Document Type: Article

References (44)

1. Acharya J.K., Labarca P., Delgado R. Synaptic defects and compensatory regulation of inositol metabolism in inositol polyphosphate 1-phosphatase mutants. Neuron. 20:1998;1219-1229.
2. Altschul S.F., Gisg W., Miller W., Myers E.W., Lipman D.J. Basic local alignment search tool. J Mol Biol. 215:1990;403-410.
3. Baker J.C., Jacobson M.K. Alteration of adenyl dinucleotide metabolism by environmental stress. Proc Natl Acad Sci USA. 83:1986;2350-2352.
4. Berridge M.J. Inositol trisphosphate and diacylglycerol. Two interacting second messengers Ann Rev Biochem. 56:1987;159-163.
5. Bessman M.J., Frick D.N., O'Handley S.F. The MutT proteins or "Nudix" hydrolases, a family of versatile, widely distributed "housecleaning" enzymes. J Biol Chem. 271:1996;25059-25062.
6. Bird A.P. CpG-rich islands and the function of DNA methylation. Nature. 321:1986;209-213.
7. Caffrey J.J., Safrany S.T., Yang X., Shears S.B. Discovery of molecular and catalytic diversity among human diphosphoinositol-polyphosphate phosphohydrolases. An expanding NUDT family J Biol Chem. 275:2000;12730z7-1212736.
8. Chen R.W., Chuang D.-M. Long-term lithium treatment suppresses p53 and Bax expression but increases bcl-2 expression. J Biol Chem. 274:1999;6039-6042.
9. Chen G., Zeng W.Z., Yuan P.X., Huang L.D., Jiang Y.M., Zhao Z.H., Manji H.K. The mood stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem. 72:1999;879-882.
10. i-protein α-subunit in rat cerebral cortex. Proc Natl Acad Sci USA. 88:1991;10634-10637.
11. De Camilli P., Emr S.D., McPherson P.S., Novick P. Phosphoinositides as regulators in membrane traffic. Science. 271:1996;1533-1539.
12. Dixon J.F., Los G.V., Hokin L.E. Lithium stimulates glutamate "release" and inositol 1,4,5-triphosphate accumulation via activation of the N-methyl-D-aspartate receptor in monkey and mouse cerebral cortex slices. Proc Natl Acad Sci USA. 91:1994;8358-8362.
13. 2 receptor mRNA in the rat striatum and nucleus accumbens. Acta Neurobiol Exp. 56:1996;29-34.
14. Feinstein D.L. Potentiation of astroglial nitric oxide synthase type-2 expression by lithium chloride. J Neurochem. 71:1998;883-886.
15. Fukuda M., Mikoshiba K. The function of inositol high polyphosphate binding proteins. Bioessays. 19:1997;593-603.
16. Hallcher L.M., Sherman W.R. The effect of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J Biol Chem. 255:1980;10896-10901.
17. Hua L.V., Green M., Warsh J.J., Li P.P. Lithium regulation of aldolase A expression in rat frontal cortex. Identification by differential display Biol Psychiat. 48:2000;58-64.
18. Inhorn R.C., Majerus P.W. Properties of inositol polyphosphate 1-phosphatase. J Biol Chem. 263:1988;14559-14565.
19. Jope R.S. Anti-bipolar therapy. Mechanism of action of lithium Mol Psychiat. 4:1999;117-128.
20. Kisselev L.L., Justesen J., Wolfson A.D., Frolova L.Y. Diadenosine oligophosphates (ApnA), a novel class of signaling molecules? FEBS Lett. 427:1998;157-163.
21. Kozak M. Interpreting cDNA sequences. Some insights from studies on translation Mamm Genome. 7:1996;563-574.
22. Li P.P., Young L.T., Tam Y.K., Warsh J.J. Effects of chronic lithium and carbamazepine treatment of G-protein subunit expression in rat cerebral cortex. Biol Psychiat. 34:1993;162-170.
23. Li P.P., Andreopoulos S., Warsh J.J. Signal transduction abnormalities in bipolar affective disorder. Reith M.E.A. Cerebral Signal Transduction. From First to Fourth Messengers:2000;283-309 Humana Press, New Jersey.
24. Manji H.K., Potter W.Z., Lenox R.H. Signal transduction pathways. Molecular targets for lithium's action Arch Gen Psychiat. 52:1995;531-543.
25. Manji H.K., Bersudsky Y., Chen G., Belmaker R.H., Potter W.Z. Modulation of protein kinase C isozymes and substrates by lithium. The role of myo-inositol Neuropsychopharmacology. 15:1996;370-381.
26. Manji H.K., Lenox R.H. Protein kinase C signaling in the brain. Molecular transduction of mood stabilization in the treatment of manic-depressive illness Biol Psychiat. 46:1999;1328-1351.
27. Miller J.C., Mathe A.A. Basal and stimulated c-fos mRNA expression in the rat brain. Effect of chronic dietary lithium Neuropsychopharmacology. 16:1997;408-418.
28. Miras-Portugal M.T., Gualix J., Pintor J. The neurotransmitter role of diadenosine polyphosphates. FEBS Lett. 430:1998;78-82.
29. Nonaka S., Chuang D.-M. Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats. Neuroreport. 9:1998;2081-2084.
30. Nonaka S., Hough C.J., Chuang D.-M. Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proc Natl Acad Sci USA. 95:1998;2642-2647.
31. Ozaki N., Chuang D.-M. Lithium increases transcription factor binding to AP-1 and cyclic AMP-responsive element in cultured neurons and rat brain. J Neurochem. 69:1997;2336-2344.
32. Safrany S.T., Caffrey J.J., Yang X., Bembenek M.E., Moyer M.B., Burkhart W.A., Shears S.B. A novel context for the "MutT" module, a guardian of cell integrity, in a diphosphoinositol polyphosphate phosphohydrolase. EMBO J. 17:1998;6599-6607.
33. Safrany S.T., Ingram S.W., Cartwright J.L., Falck J.R., McLennan A.G., Barnes L.D., Shears S.B. The diadenosine hexaphosphate hydrolases from Schizosaccharomyces pombe and Saccharomyces cerevisiae are homologues of the human diphosphoinositol polyphosphate phosphohydrolase. J Biol Chem. 274:1999;21735-21740.
34. Shamir A., Ebstein R.P., Nemanov L., Zohar A., Belmaker R.H. Inositol monophosphatase in immortalized lymphoblastoid cell lines indicates susceptibility to bipolar disorder and response to lithium therapy. Mol Psychiat. 3:1998;481-482.
35. Shears S.B. The versatility of inositol phosphates as cellular signals. Biochim Biophys Acta. 1436:1998;49-67.
36. Shelton R.C., Thase M.E., Kowatch R., Baldessarini R.J. Update on the management of bipolar illness. J Clin Psychiat. 59:1998;484-495.
37. Sivam S.P., Takeuchi K., Li S., Douglass J., Civelli O., Calvetta L., Herbert E., McGinty J.F., Hong J.S. Lithium increases dynorphin A (1-8) and prodynorphin mRNA levels in the basal ganglia. Mol Brain Res. 3:1988;155-164.
38. Sivam S.P., Krause J.E., Takeuchi K., Li S., McGinty J.F., Hong J.S. Lithium increases rat striatal beta- and gamma-preprotachykinin messenger RNAs. J Pharmacol Exp Ther. 248:1989;1297-1301.
39. Wang H.Y., Friedman E. Chronic lithium. Desensitization of autoreceptors mediating serotonin release Psychopharmacology. 94:1988;312-314.
40. Wang J.F., Young L.T. Differential display PCR reveals increased expression of 2′3′-cyclic nucleotide 3′-phosphodiesterase by lithium. FEBS Lett. 386:1996;225-229.
41. Wang J.F., Asghari V., Rockel C., Young L.T. Cyclic AMP responsive element binding protein phosphorylation and DNA binding is decreased by chronic lithium but not valproate treatment of SH-SY5Y neuroblastoma cells. Neuroscience. 91:1999;771-776.
42. Yang X., Safrany S.T., Shears S.B. Site-directed mutagenesis of diphosphoinositol polyphosphate phosphohydrolase, a dual specificity NUDT enzyme that attacks diadenosine polyphosphates and diphosphoinositol polyphosphates. J Biol Chem. 274:1999;35434-35440.
43. Yuan P.X., Chen G., Huang L.D., Manji H.K. Lithium stimulates gene expression through the AP-1 transcription factor pathway. Mol Brain Res. 58:1998;225-230.
44. Yuan P.X., Chen G., Manji H.K. Lithium activates the c-Jun NH2-terminal kinases in vitro and in the CNS in vivo. J Neurochem. 73:1999;2299-2309.